Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$28,413,419
+$5,267,189 QoQ
Shares Held
215,678
+32.2% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
3.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PFM Health Sciences, LP holds $83,113,221 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
215,678 | $28,413,419 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
39,805 | $23,603,568 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
574,666 | $17,515,819 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
930,096 | $11,561,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
145,275 | $2,019,322 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,413,419 | 215,678 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,146,230 | 163,197 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,036,193 | 57,246 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,611,471 | 12,821 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $22,768,609 | 166,803 | Shares | Defined | 2025-02-14 | |
| 2021-12-31 | $33,561,919 | 394,058 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $82,873,816 | 864,079 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $108,609,509 | 1,116,004 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $102,648,347 | 1,055,510 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||